User:Daniel Webber: Difference between revisions
Jump to navigation
Jump to search
imported>Roger A. Lohmann m (Creating user page with biography of new user.) |
No edit summary |
||
Line 1: | Line 1: | ||
{{AccountNotLive}} | |||
My primary area of intrest is into the role of glial progenitors and their potential role as stem cells. I also have an intrest in their ability as a therapeutic source in a number of animal models of neurodegenerative diseases including Alzhiemers and models of perinatal white matter damage. I also have an interest in the role of Human mesenchymal stem cells and whether they have a potential to be used as a therapeutic agent in diseases such as multiple sclerosis. I have a BSc (Hons) from University of Surrey and PhD from University of London. | My primary area of intrest is into the role of glial progenitors and their potential role as stem cells. I also have an intrest in their ability as a therapeutic source in a number of animal models of neurodegenerative diseases including Alzhiemers and models of perinatal white matter damage. I also have an interest in the role of Human mesenchymal stem cells and whether they have a potential to be used as a therapeutic agent in diseases such as multiple sclerosis. I have a BSc (Hons) from University of Surrey and PhD from University of London. | ||
[[Category:CZ Authors|Webber, Daniel]][[Category:Biology Authors|Webber, Daniel]] | [[Category:CZ Authors|Webber, Daniel]][[Category:Biology Authors|Webber, Daniel]] | ||
{{DEFAULTSORT:Webber, Daniel}} | {{DEFAULTSORT:Webber, Daniel}} |
Latest revision as of 03:42, 22 November 2023
The account of this former contributor was not re-activated after the server upgrade of March 2022.
My primary area of intrest is into the role of glial progenitors and their potential role as stem cells. I also have an intrest in their ability as a therapeutic source in a number of animal models of neurodegenerative diseases including Alzhiemers and models of perinatal white matter damage. I also have an interest in the role of Human mesenchymal stem cells and whether they have a potential to be used as a therapeutic agent in diseases such as multiple sclerosis. I have a BSc (Hons) from University of Surrey and PhD from University of London.